Unilever (UL)
(Delayed Data from NYSE)
$62.79 USD
+0.39 (0.63%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $62.82 +0.03 (0.05%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth C Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$62.79 USD
+0.39 (0.63%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $62.82 +0.03 (0.05%) 7:58 PM ET
1-Strong Buy of 5 1
D Value B Growth C Momentum B VGM
Zacks News
5 Stocks to Prepare for a Global Economic Slowdown
by Swarup Gupta
In such an event, demand for products and services generated by utilities, consumer staples and medical companies remain invariant.
UL vs. CLX: Which Stock Is the Better Value Option?
by Zacks Equity Research
UL vs. CLX: Which Stock Is the Better Value Option?
Are Investors Undervaluing Unilever PLC (UL) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Moving Average Crossover Alert: Unilever
by Zacks Equity Research
Unilever PLC (UL) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Church & Dwight (CHD) Up 20% in 6 Months: Will Momentum Stay?
by Zacks Equity Research
Church & Dwight (CHD) flaunts an impressive sales trend, owing to the strong Consumer International unit, focus on acquisitions and brand enhancement initiatives. However, margin woes remain.
The Zacks Analyst Blog Highlights: Unilever, Medifast, British American Tobacco, Sysco and J.M. Smucker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Unilever, Medifast, British American Tobacco, Sysco and J.M. Smucker
5 Consumer Staples Stocks for an Era of Soft Yields
by Swarup Gupta
Consumer staples are smart choices during a period of soft long-term rates, which signal a near-term economic slowdown.
Unilever, ADT, Levi Strauss and Stitch Fix highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Unilever, ADT, Levi Strauss and Stitch Fix highlighted as Zacks Bull and Bear of the Day
Unilever, ADT, Levi Strauss and Stitch Fix highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Unilever, ADT, Levi Strauss and Stitch Fix highlighted as Zacks Bull and Bear of the Day
Bull of the Day: Unilever (UL)
by David Borun
This naturally defensive consumer goods juggernaut is already inside your house, shouldn't it be in your portfolio, too?
New Strong Buy Stocks for March 25th
by Nitish Marwah
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
UL vs. CLX: Which Stock Is the Better Value Option?
by Zacks Equity Research
UL vs. CLX: Which Stock Is the Better Value Option?
The Zacks Analyst Blog Highlights: Otter, Pinnacle West, Duke, Archer Daniels and Unilever
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Otter, Pinnacle West, Duke, Archer Daniels and Unilever
Will Church & Dwight (CHD) Sustain its Robust Record in 2019?
by Zacks Equity Research
Church & Dwight (CHD) has been riding on strength in its Consumer International segment, benefits from acquisitions and impressive organic sales trend.
Fourth Rate Hike Likely to Raise Volatility: 5 Defensive Picks
by Swarup Gupta
A rate hike at this point would dampen investor sentiment and spark volatility.
UL vs. CLX: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
UL vs. CLX: Which Stock Is the Better Value Option?
Glaxo to Sell India's Popular Horlicks Brand to Unilever
by Zacks Equity Research
Glaxo (GSK) divests its Horlicks and other nutrition products in India to Unilever.
Glaxo's Horlicks Sale Bid Heats Up, Nestle, Unilever Close In
by Zacks Equity Research
Per a Financial Times report, Glaxo (GSK) is in exclusive talks with Unilever to sell its Horlicks brand in India. Another report in an India-based newspaper says Nestle is close to buying Horlicks.
Will Strategic Efforts Fuel Consumer Staples Growth in 2018?
by Zacks Equity Research
Stocks in the sector lagged the broader market last year, but the sector???s stock market performance wasn???t too bad: +11.6% in 2017, roughly half of the +20.2% gain for the S&P 500 index.
Can Unilever's Spreads Business Sale Drive Growth Further?
by Zacks Equity Research
Unilever PLC (UL) recently announced plans to offload its shrinking Spreads business to KKR. The deal is expected to close in mid-2018.
Unilever's Buyout of Schmidt's Naturals to Bolster Portfolio
by Zacks Equity Research
Unilever's (UL) acquisition of Schmidt's Naturals is likely to strengthen the Personal Care Business.
Apple Smashes Estimates, Starbucks Lukewarm
by Mark Vickery
Apple Inc. (AAPL) posted another big beat on both top and bottom lines after today's closing bell, where Starbucks (SBUX) was mixed.
Clorox (CLX) Trims FY18 View Despite Q1 Earnings & Sales Beat
by Zacks Equity Research
The Clorox Company (CLX) posted robust first-quarter fiscal 2018 results, wherein both top and bottom line topped estimates and grew year over year.
Archer Daniels (ADM) Topples on Q3 Earnings & Sales Miss
by Zacks Equity Research
Archer Daniels Midland Company (ADM) reported a dismal third-quarter 2017, wherein both the top and bottom lines lagged estimates and declined year over year.
Colgate (CL) Dips on Hiked Charges View, Q3 Earnings In Line
by Zacks Equity Research
Colgate-Palmolive Co. (CL) posted adjusted earnings of 73 cents a share in third-quarter 2017, in line with the Zacks Consensus Estimate and flat with the prior-year quarter.